---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-200617"
form_type: "8-K"
ticker: "ALGS"
cik: "0001799448"
company_name: "Aligos Therapeutics, Inc."
filed_at: "2023-08-01T23:59:59+00:00"
generated_at: "2026-06-12T18:46:14.229115+00:00"
event_type: "litigation"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "medium"
source: SEC EDGAR
---

# Aligos and Janssen reach agreement in principle to settle legal disputes

## Summary
- Stipulation to stay case filed July 31, 2023.
- Agreement in principle reached to resolve ongoing disputes with Janssen Biopharma.
- Parties expect to finalize settlement promptly; no financial terms disclosed.
- Litigation previously involved undisclosed claims; resolution removes legal overhang.

## SEC filing metadata
- accession: 0001193125-23-200617
- form_type: 8-K
- ticker: ALGS
- cik: 0001799448
- company_name: Aligos Therapeutics, Inc.
- filed_at: 2023-08-01T23:59:59+00:00
- event_type: litigation
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: medium
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799448/000119312523200617/0001193125-23-200617-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799448/000119312523200617/d538755d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-200617
- JSON: https://secwatch.observer/filing/0001193125-23-200617.json
- Plain text: https://secwatch.observer/filing/0001193125-23-200617.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.